Cerubidin en es it fr

Cerubidin Brand names, Cerubidin Analogs

Cerubidin Brand Names Mixture

  • No information avaliable

Cerubidin Chemical_Formula


Cerubidin RX_link


Cerubidin fda sheet


Cerubidin msds (material safety sheet)

Cerubidin MSDS

Cerubidin Synthesis Reference

J. P. Parsh et al. J. Pharm. Sci. 56, 1691 (1967);

Cerubidin Molecular Weight

527.52 g/mol

Cerubidin Melting Point

208-209 oC

Cerubidin H2O Solubility

39.2 mg/L

Cerubidin State


Cerubidin LogP


Cerubidin Dosage Forms

Powder for solution; Suspension

Cerubidin Indication

For remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.

Cerubidin Pharmacology

Daunorubicin is an antineoplastic in the anthracycline class. General properties of drugs in this class include: interaction with DNA in a variety of different ways including intercalation (squeezing between the base pairs), DNA strand breakage and inhibition with the enzyme topoisomerase II. Most of these compounds have been isolated from natural sources and antibiotics. However, they lack the specificity of the antimicrobial antibiotics and thus produce significant toxicity. The anthracyclines are among the most important antitumor drugs available. Doxorubicin is widely used for the treatment of several solid tumors while daunorubicin and idarubicin are used exclusively for the treatment of leukemia. Daunorubicin may also inhibit polymerase activity, affect regulation of gene expression, and produce free radical damage to DNA. Daunorubicin possesses an antitumor effect against a wide spectrum of tumors, either grafted or spontaneous. The anthracyclines are cell cycle-nonspecific.

Cerubidin Absorption

No information avaliable

Cerubidin side effects and Toxicity

LD50=20 mg/kg (mice, IV); LD50=13 mg/kg (rat, IV)

Cerubidin Patient Information

Cerubidin Organisms Affected

Humans and other mammals